title: Human NK cells differ more in their KIR2DL1-dependent thresholds for HLA-Cw6-mediated inhibition than in their maximal killing capacity.
abstract: In this study we have addressed the question of how activation and inhibition of human NK cells is regulated by the expression level of MHC class I protein on target cells. Using target cell transfectants sorted to stably express different levels of the MHC class I protein HLA-Cw6, we show that induction of degranulation and that of IFN-γ secretion are not correlated. In contrast, the inhibition of these two processes by MHC class-I occurs at the same level of class I MHC protein. Primary human NK cell clones were found to differ in the amount of target MHC class I protein required for their inhibition, rather than in their maximum killing capacity. Importantly, we show that KIR2DL1 expression determines the thresholds (in terms of MHC I protein levels) required for NK cell inhibition, while the expression of other receptors such as LIR1 is less important. Furthermore, using mathematical models to explore the dynamics of target cell killing, we found that the observed delay in target cell killing is exhibited by a model in which NK cells require some activation or priming, such that each cell can lyse a target cell only after being activated by a first encounter with the same or a different target cell, but not by models which lack this feature.
authors.affiliation: Division of Cell and Molecular Biology, Imperial College London, London, United Kingdom.
authors.forename: Catarina R
authors.initials: CR
authors.lastname: Almeida
authors.forename: Amit
authors.initials: A
authors.lastname: Ashkenazi
authors.forename: Gitit
authors.initials: G
authors.lastname: Shahaf
authors.forename: Deborah
authors.initials: D
authors.lastname: Kaplan
authors.forename: Daniel M
authors.initials: DM
authors.lastname: Davis
authors.forename: Ramit
authors.initials: R
authors.lastname: Mehr
mesh_terms: D017209:Apoptosis; D002478:Cells, Cultured; D002999:Clone Cells; D003602:Cytotoxicity, Immunologic / Q000276:immunology*; D005434:Flow Cytometry; D015236:HLA-C Antigens / Q000276:immunology* / Q000378:metabolism; D015395:Histocompatibility Antigens Class I / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology* / Q000378:metabolism / Q000473:pathology*; D008962:Models, Theoretical; D054342:Receptors, KIR2DL1 / Q000378:metabolism*
chemical_list: D015236:HLA-C Antigens; C528994:HLA-C*06 antigen; D015395:Histocompatibility Antigens Class I; C093100:KIR2DL1 protein, human; D054342:Receptors, KIR2DL1